<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37423763</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3296</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Thorax</Title><ISOAbbreviation>Thorax</ISOAbbreviation></Journal><ArticleTitle>Examining the effect of the COVID-19 pandemic on community virus prevalence and healthcare utilisation reveals that peaks in asthma, COPD and respiratory tract infection occur with the re-emergence of rhino/enterovirus.</ArticleTitle><Pagination><StartPage>1248</StartPage><EndPage>1253</EndPage><MedlinePgn>1248-1253</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/thorax-2022-219957</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Airway disease exacerbations are cyclical related to respiratory virus prevalence. The COVID-19 pandemic has been associated with reduced exacerbations possibly related to public health measures and their impact on non-COVID-19 respiratory viruses. We aimed to investigate the prevalence of non-COVID-19 respiratory viruses during the pandemic compared with prior in Ontario, Canada and healthcare utilisation related to asthma, chronic obstructive pulmonary disease (COPD) and respiratory tract infection.</AbstractText><AbstractText Label="METHODS">This is a population-based retrospective analysis of respiratory virus tests, emergency department (ED) visits and hospitalisations between 2015 and 2021 in Ontario. Weekly virus testing data were used to estimate viral prevalence for all non-COVID-19 respiratory viruses. We plotted the %positivity and observed and expected counts of each virus to visualise the impact of the pandemic. We used Poisson and binomial logistic regression models to estimate the change in %positivity, count of positive viral cases and count of healthcare utilisation during the pandemic.</AbstractText><AbstractText Label="RESULTS">The prevalence of all non-COVID-19 respiratory viruses decreased dramatically during the pandemic compared with prior. Comparing periods, the incidence rate ratio (IRR) for positive cases corresponded to a &gt;90% reduction for non-COVID-19 respiratory viruses except adenovirus and rhino/enterovirus. Asthma-related ED visits and hospital admissions fell by 57% (IRR 0.43 (95% CI 0.37 to 0.48)) and 61% (IRR 0.39 (95% CI 0.33 to 0.46)). COPD-related ED visits and admissions fell by 63% (IRR 0.37 (95% CI 0.30 to 0.45)) and 45% (IRR 0.55 (95% CI 0.48 to 0.62)). Respiratory tract infection ED visits and admissions fell by 85% (IRR 0.15 (95% CI 0.10 to 0.22)), and 85% (IRR 0.15 (95% CI 0.09 to 0.24)). Rather than the usual peaks in disease condition, during the pandemic, healthcare utilisation peaked in October when rhino/enterovirus peaked.</AbstractText><AbstractText Label="CONCLUSIONS">The prevalence of nearly all non-COVID-19 respiratory viruses decreased during the pandemic and was associated with marked reductions in ED visits and hospitalisations. The re-emergence of rhino/enterovirus was associated with increased healthcare utilisation.</AbstractText><CopyrightInformation>Â© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada hot4@mcmaster.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahzad</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The University of Melbourne Melbourne Medical School, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghavan</LastName><ForeName>Natya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeb</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Thorax</MedlineTA><NlmUniqueID>0417353</NlmUniqueID><ISSNLinking>0040-6376</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COPD epidemiology</Keyword><Keyword MajorTopicYN="N">COPD exacerbations</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">asthma epidemiology</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>Competing interests: TH reports grants and non-financial support from Fisher and Paykel healthcare, and personal fees from Sanofi, Astra Zeneca, and Valeo outside the submitted work, and is supported by the McMaster Department of Medicine Early Career Research Award. NR reports grants and non-financial support from Boehringer Ingelheim, and personal fees from GlaxoSmithKline outside the submitted work. NJ received unrestricted funding from Astra Zeneca Canada which was used for this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>9</Day><Hour>21</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37423763</ArticleId><ArticleId IdType="pmc">PMC10715522</ArticleId><ArticleId IdType="doi">10.1136/thorax-2022-219957</ArticleId><ArticleId IdType="pii">thorax-2022-219957</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnston NW. The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations. Proc Am Thorac Soc 2007;4:591â6. 10.1513/pats.200706-064TH</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200706-064TH</ArticleId><ArticleId IdType="pubmed">18073388</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston NW, Johnston SL, Duncan JM, et al. . The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;115:132â8. 10.1016/j.jaci.2004.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2004.09.025</ArticleId><ArticleId IdType="pmc">PMC7202457</ArticleId><ArticleId IdType="pubmed">15637559</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh K, Kim Y-E, Ji W, et al. . Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims study. Thorax 2021;76:939â41. 10.1136/thoraxjnl-2020-216526</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216526</ArticleId><ArticleId IdType="pubmed">33782081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K-PF, Kwok W-C, Ma T-F, et al. . Territory-wide study on hospital admissions for asthma exacerbations in the COVID-19 pandemic. Ann Am Thorac Soc 2021;18:1624â33. 10.1513/AnnalsATS.202010-1247OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202010-1247OC</ArticleId><ArticleId IdType="pmc">PMC8522301</ArticleId><ArticleId IdType="pubmed">33636091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dezman ZDW, Stryckman B, Zachrison KS, et al. . Masking for COVID-19 is associated with decreased emergency department utilization for non-COVID viral illnesses and respiratory conditions in Maryland. Am J Med 2021;134:1247â51. 10.1016/j.amjmed.2021.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.06.008</ArticleId><ArticleId IdType="pmc">PMC8260493</ArticleId><ArticleId IdType="pubmed">34242620</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsallakh MA, Sivakumaran S, Kennedy S, et al. . Impact of COVID-19 Lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med 2021;19:124. 10.1186/s12916-021-02000-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02000-w</ArticleId><ArticleId IdType="pmc">PMC8126470</ArticleId><ArticleId IdType="pubmed">33993870</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley H, Hadley K, Elneima O, et al. . COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res 2021;7:00718â2020. 10.1183/23120541.00718-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00718-2020</ArticleId><ArticleId IdType="pmc">PMC7607968</ArticleId><ArticleId IdType="pubmed">33527075</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, Oyelade T, Aldhahir AM, et al. . Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One 2021;16:e0255659. 10.1371/journal.pone.0255659</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255659</ArticleId><ArticleId IdType="pmc">PMC8330941</ArticleId><ArticleId IdType="pubmed">34343205</ArticleId></ArticleIdList></Reference><Reference><Citation>So JY, OâHara NN, Kenaa B, et al. . Population decline in COPD admissions during the COVID-19 pandemic associated with lower burden of community respiratory viral infections. Am J Med 2021;134:1252â9. 10.1016/j.amjmed.2021.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.05.008</ArticleId><ArticleId IdType="pmc">PMC8196237</ArticleId><ArticleId IdType="pubmed">34126098</ArticleId></ArticleIdList></Reference><Reference><Citation>
Statistic Canada . Census profile. 2021. Available: https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/details/page.cfm?Lang=E&amp;;SearchText=Ontario&amp;DGUIDlist=2021A000235&amp;GENDERlist=1,2,3&amp;STATISTIClist=1&amp;HEADERlist=0
</Citation></Reference><Reference><Citation>
Statistics Canada . Population estimates, quarterly [Internet]. n.d.
Available: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000901
</Citation></Reference><Reference><Citation>
Canadian Institute for Health Information . Canadian COVID-19 intervention timeline. n.d.
Available: https://www.cihi.ca/en/canadian-covid-19-intervention-timeline
</Citation></Reference><Reference><Citation>Cave AJ, Soos B, Gillies C, et al. . Validating a case definition for adult asthma in primary care electronic medical records. NPJ Prim Care Respir Med 2020;30:24. 10.1038/s41533-020-0181-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41533-020-0181-3</ArticleId><ArticleId IdType="pmc">PMC7275082</ArticleId><ArticleId IdType="pubmed">32503968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho TW, Ruan SY, Huang CT, et al. . Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from national health insurance claim data in Taiwan. Int J Chron Obstruct Pulmon Dis 2018;13:3055â63. 10.2147/COPD.S174265</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S174265</ArticleId><ArticleId IdType="pmc">PMC6174682</ArticleId><ArticleId IdType="pubmed">30323577</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton MA, Calzavara A, Emerson SD, et al. . Validating International classification of disease 10th revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS One 2021;16:e0244746. 10.1371/journal.pone.0244746</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244746</ArticleId><ArticleId IdType="pmc">PMC7790248</ArticleId><ArticleId IdType="pubmed">33411792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, DâSouza AG, Quan H, et al. . Validity of ICD-10 codes for COVID-19 patients with hospital admissions or ED visits in Canada: a retrospective cohort study. BMJ Open 2022;12:e057838. 10.1136/bmjopen-2021-057838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057838</ArticleId><ArticleId IdType="pmc">PMC8787827</ArticleId><ArticleId IdType="pubmed">35063962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a Tutorial. Int J Epidemiol 2016;46:dyw098. 10.1093/ije/dyw098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw098</ArticleId><ArticleId IdType="pmc">PMC5407170</ArticleId><ArticleId IdType="pubmed">27283160</ArticleId></ArticleIdList></Reference><Reference><Citation>Park KY, Seo S, Han J, et al. . Respiratory virus surveillance in Canada during the COVID-19 pandemic: an epidemiological analysis of the effectiveness of pandemic-related public health measures in reducing seasonal respiratory viruses test positivity. PLoS One 2021;16:e0253451. 10.1371/journal.pone.0253451</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253451</ArticleId><ArticleId IdType="pmc">PMC8213179</ArticleId><ArticleId IdType="pubmed">34143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic â United States, 2020â2021. MMWR Morb Mortal Wkly Rep 2021;70:1013â9. 10.15585/mmwr.mm7029a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7029a1</ArticleId><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers L, Sheppard M, Smith A, et al. . Changes in seasonal respiratory illnesses in the United States during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis 2021;73:S110â7. 10.1093/cid/ciab311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab311</ArticleId><ArticleId IdType="pmc">PMC8135472</ArticleId><ArticleId IdType="pubmed">33912902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JY, Conceicao EP, Wee LE, et al. . COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax 2021;76:512â3. 10.1136/thoraxjnl-2020-216083</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216083</ArticleId><ArticleId IdType="pubmed">33273024</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Xu M, Cao L, et al. . Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China. Virol J 2021;18:159. 10.1186/s12985-021-01627-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01627-8</ArticleId><ArticleId IdType="pmc">PMC8329611</ArticleId><ArticleId IdType="pubmed">34344406</ArticleId></ArticleIdList></Reference><Reference><Citation>
Pathogens [Internet]. 2022. Available: https://seattleflu.org/pathogens
</Citation></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2023;21:195â210. 10.1038/s41579-022-00807-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R-X, Chen D-M, Qian Y, et al. . Surges of hospital-based rhinovirus infection during the 2020 Coronavirus Disease-19 (COVID-19) pandemic in Beijing, China. World J Pediatr 2021;17:590â6. 10.1007/s12519-021-00477-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00477-2</ArticleId><ArticleId IdType="pmc">PMC8552974</ArticleId><ArticleId IdType="pubmed">34713393</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Michelow IC, Choe YJ. Shifting patterns of respiratory virus activity following social distancing measures for Coronavirus disease 2019 in South Korea. J Infect Dis 2021;224:1900â6. 10.1093/infdis/jiab231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab231</ArticleId><ArticleId IdType="pmc">PMC8135809</ArticleId><ArticleId IdType="pubmed">34009376</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>